chAIron blends AI with human expertise to revolutionize R&D. Our goal is to identify new indications innovatively and unlock the full potential of companies’ assets. We believe in continuously pushing the boundaries of technology and individuals to make a positive impact on people’s lives.
Products, services, technology
- Indication Discovery: Our AI-driven analysis unlocks new indications for novel and existing drugs.
- Maximizing Asset Value: We assess molecules with a data-driven approach, guiding strategic decisions on programs' development based on scientific viability, technical feasibility, and market impact.
Cooperation possibilities
We offer tailored strategic decision-making analysis and advice for R&D leaders, business development teams, and industry investors. Our expertise includes roadmaps for clinical and corporate strategies to minimise risk in the research-to-market journey and guiding decisions in partnerships and M&A.
- https://www.chairon.io
- contact@chairon.io
- Rodrigo Hernandez Canteli
Some insights
- Pharma companies (i) with assets idle on the shelf (e.g., from failed trials), (ii) seeking to expand the life cycle of commercialised assets by exploring potential new indications, and (iii) owning new molecules in Phase I.
- Biotech players with programs in the early stages of development.
We disrupt and innovate pharmaceutical research by uncovering new indications for molecules, thereby increasing the probability of developing new treatments and improving patient outcomes.
At chAIron we are proud of our role in revolutionizing clinical research by efficiently using complex datasets, AI, and expert insights to accelerate the development of new treatments, bringing vital medicines to patients faster and more resourcefully.
Our team excels in integrating real-world data, omics data, literature, AI, clinical expertise, and business proficiency to advance drug development. Looking ahead, we aim to enhance our platform of services by vertically integrating cutting-edge technology and data analytics skills.
Our families say we are ‘medicine detectives’, using computers and science to find new ways to make people healthier and happier, quicker.
With its focus on fostering innovation, it can aid our mission to advance therapeutic development and advance the ecosystem’s global position by providing access to its network of talented professionals and industry leaders, as well as various resources to create long-term partnerships.